Create Alert
Watchlist

Gland Pharma

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹32,964Cr
ROE7.63%
P/E Ratio(TTM)47.19
EPS(TTM)42.40
P/B Ratio3.60
Dividend Yield0.90%
Industry P/E35.91
Book Value555.41
Debt to Equity0.03
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Gland Pharma

Gland Pharma Limited is an India-based generic injectable-focused company. The Company specializes in complex injectables and is engaged in the sterile injectables, oncology, and ophthalmology segments. The Company provides contract development, own development, dossier preparation and filing, technology transfer and manufacturing across a variety of delivery systems. Its products are available in liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns, Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients. Its products are sold across various countries, which include United States, Europe, Canada, and others.;
Parent OrganisationGland Pharma Limited
Managing DirectorMr. Srinivasa Sadu
NSE SymbolGLAND

Shareholding Pattern

Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Promoters
51.83%
Mutual Funds
31.16%
Retail And Others
7.99%
Foreign Institutions
6.90%
Other Domestic Institutions
2.11%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
62.37
Ajanta Pharma
NA
(0.00%)
37.63
Eris Lifesciences
NA
(0.00%)
68.29
Sai Life Sciences
NA
(0.00%)
100.03